Back
Vista Energy SAB de CV Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
71
VIST
Vista Energy SAB de CV
Last Price:
47.64
Seasonality Move:
15.04%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Buy
71
Vista Energy SAB de CV (VIST)
is a Buy
Is Vista Energy SAB de CV a Buy, Sell or Hold?
- The current Vista Energy SAB de CV [VIST] share price is $47.63. The Score for VIST is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- VIST is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIST Stock Price Chart
What is Vista Energy SAB de CV's stock price today?
-
The Vista Energy SAB de CV share price today is $47.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIST is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
VIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 43.96 | Sell |
| Chaikin Money Flow: | -483446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.7 - 50.56) | Sell |
| Bollinger Bands (100): | (44.72 - 49.86) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 225492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.67) | Buy |
| Bollinger Bands (100): | (57.7 - 62.92) | Buy |
VIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.6 | Sell |
| 20-day SMA: | 49.3 | Sell |
| 50-day SMA: | 48.39 | Sell |
| 200-day SMA: | 43.97 | Buy |
| 8-day EMA: | 49.27 | Sell |
| 20-day EMA: | 49.22 | Sell |
| 50-day EMA: | 48.47 | Sell |
| 200-day EMA: | 43.4 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.22 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 62.04 | Sell |
| 8-day EMA: | 58.8 | Buy |
| 20-day EMA: | 58.52 | Buy |
| 50-day EMA: | 58.98 | Buy |
| 200-day EMA: | 59.88 | Buy |
Vista Energy SAB de CV Earnings Growth & VIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.86 per share, and an increase next year of $0.85 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
Vista Energy SAB de CV Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||